AAAAAA

   
Results: 1-18 |
Results: 18
Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy
Authors: Duong, M Petit, JM Piroth, L Grappin, M Buisson, M Chavanet, P Hillon, S Portier, H
Citation: M. Duong et al., Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virus-coinfected patients undergoing antiretroviraltherapy, J ACQ IMM D, 27(3), 2001, pp. 245-250
Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response
Authors: Duong, M Piroth, L Peytavin, G Forte, F Kohli, E Grappin, M Buisson, M Chavanet, P Portier, H
Citation: M. Duong et al., Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: Relationship to virologic response, CLIN INF D, 33(3), 2001, pp. 386-392
Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review
Authors: Duong, M Buisson, M Cottin, Y Piroth, L Lhuillier, I Grappin, M Chavanet, P Wolff, JE Portier, H
Citation: M. Duong et al., Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: Report of four cases and review, CLIN CARD, 24(10), 2001, pp. 690-694
Incidence of gynecomastia in men infected with HIV and treated with highlyactive antiretroviral therapy
Authors: Piroth, L Grappin, M Petit, JM Buisson, M Duong, M Chavanet, P Portier, H
Citation: L. Piroth et al., Incidence of gynecomastia in men infected with HIV and treated with highlyactive antiretroviral therapy, SC J IN DIS, 33(7), 2001, pp. 559-560
Functional determinants of the Epstein-Barr virus protease
Authors: Buisson, M Valette, E Hernandez, JF Baudin, F Ebel, C Morand, P Seigneurin, JM Arlaud, GJ Ruigrok, RWH
Citation: M. Buisson et al., Functional determinants of the Epstein-Barr virus protease, J MOL BIOL, 311(1), 2001, pp. 217-228
Incomplete genotypic resistance to nonnucleoside reverse transcriptase inhibitors in patients treated with nevirapine: A potential interest in clinical practice
Authors: Grappin, M Piroth, L Kohli, E Buisson, M Duong, M Chavanet, P Portier, H
Citation: M. Grappin et al., Incomplete genotypic resistance to nonnucleoside reverse transcriptase inhibitors in patients treated with nevirapine: A potential interest in clinical practice, J ACQ IMM D, 25(5), 2000, pp. 464-465
Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy
Authors: Piroth, L Grappin, M Buisson, M Duong, M Portier, H Chavanet, P
Citation: L. Piroth et al., Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy, J ACQ IMM D, 23(4), 2000, pp. 356-357
Recurrent NNRTI-induced hepatotoxicity in an HIV-HCV-coinfected patient
Authors: Piroth, L Grappin, M Sgro, C Buisson, M Duong, M Chavanet, P
Citation: L. Piroth et al., Recurrent NNRTI-induced hepatotoxicity in an HIV-HCV-coinfected patient, ANN PHARMAC, 34(4), 2000, pp. 534-535
Increased prevalence of subclinical hypothyroidism in HIV patients treatedwith highly active antiretroviral therapy
Authors: Grappin, M Piroth, L Verges, B Sgro, C Mack, G Buisson, M Duong, M Chavanet, P Portier, H
Citation: M. Grappin et al., Increased prevalence of subclinical hypothyroidism in HIV patients treatedwith highly active antiretroviral therapy, AIDS, 14(8), 2000, pp. 1070-1072
Epstein-Barr virus EB2 protein exports unspliced RNA via a Crm-1-independent pathway
Authors: Farjot, G Buisson, M Dodon, MD Gazzolo, L Sergeant, A Mikaelian, I
Citation: G. Farjot et al., Epstein-Barr virus EB2 protein exports unspliced RNA via a Crm-1-independent pathway, J VIROLOGY, 74(13), 2000, pp. 6068-6076
Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factors
Authors: Aho, S Buisson, M Pajunen, T Ryoo, YW Giot, JF Gruffat, H Sergeant, A Uitto, J
Citation: S. Aho et al., Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factors, J CELL BIOL, 148(6), 2000, pp. 1165-1176
Human herpesvirus 8 and Epstein Barr-Virus in a cutaneons B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient
Authors: Morand, P Buisson, M Collandre, H Chanzy, B Genoulaz, O Bourgeat, MJ Pinel, N Leclercq, P Leroux, D Marechal, V Fritsch, L Ruigrok, R Seigneurin, JM
Citation: P. Morand et al., Human herpesvirus 8 and Epstein Barr-Virus in a cutaneons B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient, LEUK LYMPH, 35(3-4), 1999, pp. 379-387
Development of an Epstein-Barr virus type 2 (EBV-2)-associated hepatic B cell non-Hodgkin's lymphoma in an HIV-1-infected patient following a change in the EBV dominant type
Authors: Buisson, M Morand, P Peoc'h, M Bouchard, O Bourgeat, ML Seigneurin, JM
Citation: M. Buisson et al., Development of an Epstein-Barr virus type 2 (EBV-2)-associated hepatic B cell non-Hodgkin's lymphoma in an HIV-1-infected patient following a change in the EBV dominant type, LEUKEMIA, 13(2), 1999, pp. 298-301
Discontinuation of protease inhibitors due to intolerance: a longitudinal study in 309 HIV-1 positive patients
Authors: Piroth, L Grappin, M Waldner, A Sgro, C Duong, M Buisson, M Chavanet, P Portier, H
Citation: L. Piroth et al., Discontinuation of protease inhibitors due to intolerance: a longitudinal study in 309 HIV-1 positive patients, PRESSE MED, 28(8), 1999, pp. 381-387
Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation
Authors: Buisson, M Fleurent, B Mak, M Morand, P Chan, L Ng, A Guan, M Chin, D Seigneurin, JM
Citation: M. Buisson et al., Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation, J CLIN MICR, 37(8), 1999, pp. 2709-2714
Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics
Authors: Piroth, L Martin, L Coulon, A Lequeu, C Duong, M Buisson, M Portier, H Chavanet, P
Citation: L. Piroth et al., Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics, ANTIM AG CH, 43(10), 1999, pp. 2484-2492
The C-terminal region but not the Arg-X-Pro repeat of Epstein-Barr virus protein EB2 is required for its effect on RNA splicing and transport
Authors: Buisson, M Hans, F Kusters, I Duran, N Sergeant, A
Citation: M. Buisson et al., The C-terminal region but not the Arg-X-Pro repeat of Epstein-Barr virus protein EB2 is required for its effect on RNA splicing and transport, J VIROLOGY, 73(5), 1999, pp. 4090-4100
Different distribution of H1-H2 Epstein-Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from Algeria (vol 77, pg 205, 1998)
Authors: Bouzid, M Sheng, W Buisson, M Bouguermouh, A Morand, P Seigneurin, JM Ooka, T
Citation: M. Bouzid et al., Different distribution of H1-H2 Epstein-Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from Algeria (vol 77, pg 205, 1998), INT J CANC, 80(3), 1999, pp. 485-485
Risultati: 1-18 |